Table 3:
One-, two-, and five-year survival probabilities by treatment modality and cohort from day 1 of the start of KRT, dialysis, or from the day of kidney transplantation.
| Survival probabilities as % (95% confidence intervals) | |||||
|---|---|---|---|---|---|
| Cohort: 2012–2016 | Cohort: 2015–2019 | ||||
| Survival type | 1 year | 2 year | 5 year | 1 year | 2 year |
| Patient survival on KRT | |||||
| Unadjusted | 85.1 (84.9–85.3) | 75.1 (74.9–75.3) | 51.7 (51.4–51.9) | 85.7 (85.6–85.9) | 75.7 (75.5–75.9) |
| Adjusteda | 87.9 (87.7–88.0) | 78.9 (78.7–79.1) | 54.1 (53.8–54.3) | 88.3 (88.2–88.5) | 79.2 (79.0–79.4) |
| Patient survival on dialysis | |||||
| Unadjusted | 84.0 (83.8–84.2) | 72.4 (72.2–72.6) | 41.4 (41.1–41.7) | 84.7 (84.5–84.8) | 73.0 (72.8–73.2) |
| Adjusteda | 86.2 (86.1–86.4) | 75.9 (75.7–76.1) | 46.6 (46.3–46.9) | 87.0 (86.9–87.2) | 76.6 (76.5–77.0) |
| Patient survival after a first kidney transplantation (deceased donor) | |||||
| Unadjusted | 96.2 (96.0–96.4) | 94.1 (93.9–94.3) | 85.8 (85.4–86.1) | 96.4 (96.2–96.5) | 93.9 (93.7–94.1) |
| Adjustedb | 98.0 (97.9–98.2) | 96.9 (96.8–97.1) | 92.1 (91.8–92.4) | 98.1 (98.0–98.2) | 96.8 (96.7–97.0) |
| Graft survival after a first kidney transplantation (deceased donor) | |||||
| Unadjusted | 91.1 (90.8–91.4) | 87.9 (87.6–88.2) | 77.0 (76.6–77.5) | 91.4 (91.1–91.7) | 88.0 (87.7–88.3) |
| Adjustedb | 93.1 (92.8–93.3) | 90.5 (90.2–90.8) | 81.4 (81.0–81.9) | 93.4 (93.2–93.6) | 90.7 (90.4–91.0) |
| Patient survival after a first kidney transplantation (living donor) | |||||
| Unadjusted | 98.9 (98.7–99.0) | 98.0 (97.7–98.2) | 94.2 (93.8–94.6) | 98.9 (98.6–99.0) | 97.9 (97.7–98.2) |
| Adjustedb | 99.1 (98.9–99.2) | 98.3 (98.1–98.6) | 95.1 (94.7–95.5) | 99.1 (98.9–99.3) | 98.4 (98.1–98.6) |
| Graft survival after a first kidney transplantation (living donor) | |||||
| Unadjusted | 96.7 (96.3–97.0) | 95.1 (94.7–95.4) | 88.3 (87.7–88.8) | 96.8 (96.5–97.1) | 95.2 (94.8–95.6) |
| Adjustedb | 96.5 (96.2–96.9) | 94.9 (94.5–95.3) | 87.7 (87.1–88.3) | 96.6 (96.3–97.0) | 95.0 (94.6–95.4) |
aAnalyses were adjusted using fixed values: age (67 years), sex (63% male), and PRD (24% diabetes mellitus, 19% hypertension/renal vascular disease, 11% glomerulonephritis, and 46% other causes)
bAnalyses were adjusted using fixed values: age (50 years), sex (63% men), and PRD (14% diabetes mellitus, 10% hypertension/renal vascular disease, 23% glomerulonephritis, and 53% other causes)
This table is based on data from the following registries providing individual patient data: Austria, Belgium (Dutch-speaking), Belgium (French-speaking), Bosnia and Herzegovina, Denmark, Estonia, Finland, France, Greece, Iceland, Norway, Spain (Andalusia), Spain (Aragon), Spain (Asturias), Spain (Basque country), Spain (Cantabria), Spain (Castile and León), Spain (Castile-La Mancha), Spain (Catalonia), Spain (Community of Madrid), Spain (Extremadura), Spain (Galicia), Spain (Murcia), Spain (Navarre), Spain (Valencian Region), Sweden, the Netherlands, United Kingdom (England/Northern Ireland/Wales) and United Kingdom (Scotland).